Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Tonix Pharmaceuticals Holding (TNXP) Leases (2023 - 2025)

Tonix Pharmaceuticals Holding (TNXP) has 3 years of Leases data on record, last reported at $376000.0 in Q3 2025.

  • For Q3 2025, Leases fell 40.13% year-over-year to $376000.0; the TTM value through Sep 2025 reached $376000.0, down 40.13%, while the annual FY2024 figure was $565000.0, 31.43% down from the prior year.
  • Leases reached $376000.0 in Q3 2025 per TNXP's latest filing, down from $438000.0 in the prior quarter.
  • Across five years, Leases topped out at $898000.0 in Q2 2023 and bottomed at $376000.0 in Q3 2025.
  • Average Leases over 3 years is $645909.1, with a median of $628000.0 recorded in 2024.
  • Peak YoY movement for Leases: soared 43.37% in 2024, then plummeted 40.13% in 2025.
  • A 3-year view of Leases shows it stood at $824000.0 in 2023, then crashed by 31.43% to $565000.0 in 2024, then tumbled by 33.45% to $376000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Leases were $376000.0 in Q3 2025, $438000.0 in Q2 2025, and $501000.0 in Q1 2025.